CYP2A6 Genotype but not Age Determines Cotinine Half-life in Infants and Children

The formation of cotinine, the main proximate metabolite and a biomarker of nicotine exposure, is mediated primarily by cytochrome P450 (CYP)2A6. Our aim was to determine whether higher cotinine levels in young children exposed to secondhand smoke (SHS) are a result of age‐related differences in pharmacokinetics. Forty‐nine participants, aged 2–84 months, received oral deuterium‐labeled cotinine, with daily urine samples for up to 10 days for cotinine half‐life measurement. DNA from saliva was used for CYP2A6 genotyping. The estimate of half‐life using a mixed‐effect model was 17.9 h (95% confidence interval: 16.5, 19.3), similar to that reported in adults. There was no statistically significant effect of sex, race, age, or weight. Children with normal‐activity CYP2A6*1/*1 genotypes had a shorter half‐life than those with one or two reduced‐activity variant alleles. Our data suggest that higher cotinine levels in SHS‐exposed young children as compared with adults are due to greater SHS exposure rather than to different cotinine pharmacokinetics.

• Publication year

  2013

• Venue

  Clinical pharmacology and therapy

• Publication date

  2013-05-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/clpt.2013.114PMID 23714690PMCID 3820275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Spatial structures of health outcomes and health behaviours in Scotland: Evidence from the Scottish Health Survey

  2014cited by this paper
• The Ability of Plasma Cotinine to Predict Nicotine and Carcinogen Exposure is Altered by Differences in CYP2A6: the Influence of Genetics, Race, and Sex

  2013cited by this paper
• Determination of tobacco smoke exposure by plasma cotinine levels in infants and children attending urban public hospital clinics.

  2012cited by this paper
• Hair nicotine/cotinine concentrations as a method of monitoring exposure to tobacco smoke among infants and adults

  2012cited by this paper
• Cytostatic drugs in infants: a review on pharmacokinetic data in infants.

  2012cited by this paper
• Determination of the nicotine metabolites cotinine and trans-3'-hydroxycotinine in biologic fluids of smokers and non-smokers using liquid chromatography-tandem mass spectrometry: biomarkers for tobacco smoke exposure and for phenotyping cytochrome P450 2A6 activity.

  2011cited by this paper
• Developmental pharmacokinetics.

  2011cited by this paper
• Hepatic CYP2A6 levels and nicotine metabolism: impact of genetic, physiological, environmental, and epigenetic factors

  2010cited by this paper
• Objectively measured secondhand smoke exposure and mental health in children: evidence from the Scottish Health Survey.

  2010cited by this paper
• Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African‐American Light Smokers

  2009cited by this paper
• A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo

  2009cited by this paper
• Nicotine chemistry, metabolism, kinetics and biomarkers.

  2009cited by this paper
• Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent

  2008cited by this paper
• CYP2A6 genotype and the metabolism and disposition kinetics of nicotine

  2006cited by this paper
• Metabolism and Disposition Kinetics of Nicotine

  2005cited by this paper
• The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.

  2004cited by this paper
• Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians.

  2004cited by this paper
• Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity

  2004cited by this paper
• Agreement between maternal self-reported ethanol intake and tobacco use during pregnancy and meconium assays for fatty acid ethyl esters and cotinine.

  2003cited by this paper
• Environmental tobacco smoke exposure in low-income 6-year-olds: parent report and urine cotinine measures.

  2003cited by this paper
• Nicotine metabolism and elimination kinetics in newborns

  2000cited by this paper
• The elimination half-life of urinary cotinine in children of tobacco-smoking mothers.

  1998cited by this paper
• Nicotine metabolism and intake in black and white smokers.

  1998cited by this paper
• What determines levels of passive smoking in children with asthma?

  1997cited by this paper
• Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs.

  1996cited by this paper
• Cotinine as a biomarker of environmental tobacco smoke exposure.

  1996cited by this paper
• Metabolism of nicotine to cotinine studied by a dual stable isotope method

  1994cited by this paper
• Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.

  1994cited by this paper
• Cotinine Elimination and Its Use as a Biomarker in Young Children Involuntarily Exposed to Environmental Tobacco Smoke

  1994cited by this paper
• Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans.

  1991cited by this paper
• Urine cotinine excretion in neonates exposed to tobacco smoke products in utero.

  1985cited by this paper

• Inhibition of Benzo[a]pyrene-induced DNA Adduct in Buccal Cells of Smokers by Black Raspberry Lozenges.

  2024cites this paper
• The Effects of Black Raspberry as a Whole Food-Based Approach on Biomarkers of Oxidative Stress in Buccal Cells and Urine of Smokers.

  2024cites this paper
• Evaluation of common carotid artery wall stiffness by shear wave elastography in smokers and non-smokers

  2024cites this paper
• Inflammatory marker levels in children with tobacco smoke exposure.

  2023cites this paper
• The Associations of Trans-3′-Hydroxy Cotinine, Cotinine, and the Nicotine Metabolite Ratio in Pediatric Patients with Tobacco Smoke Exposure

  2023cites this paper
• Diagnostic Performance Evaluation of the Novel Index Combining Urinary Cotinine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol in Smoking Status Verification and Usefulness for Trend Monitoring of Tobacco Smoking Exposure

  2022cites this paper
• Passive exposure to electronic cigarette aerosol in pregnancy: A case study of a family.

  2022cites this paper
• Carcinogenic and Tobacco Smoke-Derived Particulate Matter Biomarker Uptake and Associated Healthcare Patterns among Children

  2022cites this paper
• Hand nicotine as an independent marker of thirdhand smoke pollution in children’s environments

  2022influential citation
• Ontogeny of Drug-Metabolizing Enzymes.

  2021cites this paper
• Differential associations of hand nicotine and urinary cotinine with children's exposure to tobacco smoke and clinical outcomes.

  2021cites this paper
• Comparison of Levels of Three Tobacco Smoke Exposure Biomarkers in Children of Smokers

  2021cites this paper
• Assessing secondhand and thirdhand tobacco smoke exposure in Canadian infants using questionnaires, biomarkers, and machine learning

  2021cites this paper
• Comparison of Liquid Chromatography Mass Spectrometry and Enzyme-Linked Immunosorbent Assay Methods to Measure Salivary Cotinine Levels in Ill Children

  2020cites this paper
• Use of a physiologically-based pharmacokinetic model to explore the potential disparity in nicotine disposition between adult and adolescent nonhuman primates.

  2019cites this paper
• Effects of maternal tobacco smoking on breast milk composition and infant development: a literature review

  2019cites this paper
• Association between maternal passive smoking and increased risk of delivering small-for-gestational-age infants at full-term using plasma cotinine levels from The Hokkaido Study: a prospective birth cohort

  2019cites this paper
• Evaluating metronidazole as a novel, safe CYP2A6 phenotyping probe in healthy adults

  2019cites this paper
• Decreasing trend in passive tobacco smoke exposure and association with asthma in U.S. children

  2018cites this paper
• The feasibility of an air purifier and secondhand smoke education intervention in homes of inner city pregnant women and infants living with a smoker

  2018influential citation
• Hepatic Drug Metabolism in Pediatric Patients

  2017cites this paper
• Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation

  2017cites this paper
• Association of prenatal passive smoking and metabolic gene polymorphisms with child growth from birth to 3years of age in the Hokkaido Birth Cohort Study on Environment and Children's Health.

  2017cites this paper
• Urine Cotinine Screening Detects Nearly Ubiquitous Tobacco Smoke Exposure in Urban Adolescents.

  2017cites this paper
• Advances in Medicinal Plants with Effects on Anxiety Behavior Associated to Mental and Health Conditions.

  2017cites this paper
• Sources of Variation in Nicotine Metabolism and Associations with Smoking Abstinence in Adolescents and Adults

  2016cites this paper
• Urine Cotinine Screening Detects Nearly Ubiquitous Tobacco Smoke Exposure in Urban Adolescents

  2016cites this paper
• Tobacco smoking and breastfeeding: Effect on the lactation process, breast milk composition and infant development. A critical review.

  2016cites this paper
• Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?

  2016cites this paper
• Combined effects of AHR, CYP1A1, and XRCC1 genotypes and prenatal maternal smoking on infant birth size: Biomarker assessment in the Hokkaido Study.

  2016cites this paper
• Trends in exposure to second hand smoke at home among children and nonsmoker adolescents.

  2016cites this paper
• Pharmacokinetic considerations when prescribing in children

  2016cites this paper
• Meta‐analysis of hepatic cytochrome P450 ontogeny to underwrite the prediction of pediatric pharmacokinetics using physiologically based pharmacokinetic modeling

  2016cites this paper
• Systemic exposure to menthol following administration of peppermint oil to paediatric patients

  2015cites this paper
• Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease

  2015cites this paper
• Relationship between Urinary N-Desmethyl-Acetamiprid and Typical Symptoms including Neurological Findings: A Prevalence Case-Control Study

  2015cites this paper
• The Interaction Between Genetics and Tobacco Consumption in Light Smokers

  2014cites this paper